about
Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Usin...
Read More
1.17
-0.09
(-7.14%)
24,377
XNAS Volume
High volume+loss today
XNAS 23 Jun, 2025 4:00 PM (EDT)
Not Eligible
Mid Valuation
Technically Neutral
Synlogic Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..